Extendicare Inc. (TSE:EXE - Get Free Report)'s share price hit a new 52-week high on Tuesday . The stock traded as high as C$9.52 and last traded at C$9.50, with a volume of 47685 shares. The stock had previously closed at C$9.48.
Analysts Set New Price Targets
Several research analysts have commented on EXE shares. TD Securities lifted their target price on Extendicare from C$9.00 to C$9.50 and gave the stock a "hold" rating in a report on Wednesday, September 4th. Royal Bank of Canada increased their target price on shares of Extendicare from C$8.50 to C$9.50 in a research report on Monday, August 19th.
Check Out Our Latest Stock Analysis on EXE
Extendicare Stock Performance
The stock has a market cap of C$787.96 million, a P/E ratio of 13.88 and a beta of 1.26. The company has a current ratio of 0.60, a quick ratio of 0.98 and a debt-to-equity ratio of 305.80. The company's 50-day simple moving average is C$8.44 and its 200 day simple moving average is C$7.78.
Extendicare (TSE:EXE - Get Free Report) last issued its quarterly earnings results on Monday, August 12th. The company reported C$0.29 earnings per share for the quarter. Extendicare had a net margin of 4.28% and a return on equity of 60.00%. The company had revenue of C$348.48 million for the quarter, compared to the consensus estimate of C$360.20 million. As a group, sell-side analysts expect that Extendicare Inc. will post 0.6134729 EPS for the current fiscal year.
Extendicare Dividend Announcement
The business also recently declared a monthly dividend, which will be paid on Tuesday, October 15th. Investors of record on Monday, September 30th will be issued a $0.04 dividend. The ex-dividend date is Friday, September 27th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 5.08%. Extendicare's dividend payout ratio (DPR) is presently 70.59%.
Extendicare Company Profile
(
Get Free Report)
Extendicare Inc, through its subsidiaries, provides care and services for seniors in Canada. The company offers long term care (LTC) services; and home health care services, such as nursing care, occupational, physical and speech therapy, and assistance with daily activities, as well as management, consulting, and other services to third parties.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Extendicare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Extendicare wasn't on the list.
While Extendicare currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
